NCT02326974 2026-04-17
T-DM1+Pertuzumab in Pre-OP Early-Stage HER2+ BRCA
Dana-Farber Cancer Institute
Phase 2 Active not recruiting
Dana-Farber Cancer Institute
National Cancer Institute (NCI)
Eastern Cooperative Oncology Group
Memorial Sloan Kettering Cancer Center
Haukeland University Hospital
Dana-Farber Cancer Institute
Cedars-Sinai Medical Center
Beni-Suef University
University of Maryland, Baltimore
Jilin University
Gustave Roussy, Cancer Campus, Grand Paris
Washington University School of Medicine
Washington University School of Medicine
Clinique Clementville